Fermenta Biotech Ltd () News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 261671,
    "name": "Fermenta Biotec.",
    "stock_name": "Fermenta Biotec.",
    "full_name": "Fermenta Biotech Ltd",
    "name_url": "stocks-analysis/fermenta-biotec",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "262.05",
    "chg": -2.5,
    "chgp": "-0.95%",
    "dir": -1,
    "prev_price": "264.55",
    "mcapval": "771.24 Cr",
    "mcap": "Micro Cap",
    "scripcode": 506414,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE225B01021",
    "curr_date": "Dec 05",
    "curr_time": "",
    "bse_nse_vol": "2.14 k",
    "exc_status": "Active",
    "traded_date": "Dec 05, 2025",
    "traded_date_str": "2025 12 05",
    "score": "",
    "scoreText": "",
    "Live": 1,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/fermenta-biotec-261671-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Fermenta Biotec. Sees Revision in Market Evaluation Amid Mixed Financial Signals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/fermenta-biotec-downgraded-to-sell-by-marketsmojo-amid-weak-fundamentals-3737190",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/FermentaBiotec_mojoScore_3737190.png",
        "date": "2025-11-30 10:24:23",
        "description": "Fermenta Biotec., a microcap player in the Pharmaceuticals & Biotechnology sector, has experienced a revision in its market evaluation reflecting shifts in its fundamental and technical outlook. This adjustment follows a detailed reassessment of the company’s quality, valuation, financial trends, and technical indicators, providing investors with a nuanced perspective on its current standing."
      },
      {
        "title": "Fermenta Biotech Faces Bearish Technical Trends Amid Mixed Performance Indicators",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/fermenta-biotechs-technical-trend-changes-from-mildly-bearish-to-bearish-amid-stock-price-decline-3710092",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/FermentaBiotech_technicaldot_3710092.png",
        "date": "2025-11-18 08:03:45",
        "description": "Fermenta Biotech, a microcap in the Pharmaceuticals and Biotechnology sector, has seen its stock price decline recently, reflecting mixed performance against the Sensex. While it has outperformed the index monthly and over three years, year-to-date results show significant challenges, necessitating close monitoring of market conditions."
      },
      {
        "title": "Why is Fermenta Biotec. falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-fermenta-biotec-fallingrising-3708338",
        "imagepath": "",
        "date": "2025-11-17 22:24:03",
        "description": "As of 17-Nov, Fermenta Biotech Ltd's stock is currently priced at 276.80, reflecting a decline of 15.05 points or 5.16%. The stock has been underperforming, having fallen consecutively for the last two days with a total drop of 5.19%. It opened the day with a loss of 2.18% and reached an intraday low of Rs 274.5, which is a decrease of 5.94%. The stock's performance over the past week shows a slight decline of 0.18%, while it has gained 5.07% over the past month. However, year-to-date, it is down 23.95%, contrasting sharply with the Sensex, which has increased by 8.72%. There is a notable decrease in investor participation, with delivery volume dropping by 62.9% compared to the five-day average, indicating a lack of confidence among investors.\n\nBroader Market Context: In the context of the broader market, Fermenta Biotech's recent performance has been unfavorable compared to the Sensex, which has gained 1.6..."
      },
      {
        "title": "Is Fermenta Biotec. technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-fermenta-biotec-technically-bullish-or-bearish-3700156",
        "imagepath": "",
        "date": "2025-11-14 08:10:47",
        "description": "As of 13 November 2025, the technical trend for Fermenta Biotec has changed from bearish to mildly bearish. The current stance is mildly bearish, primarily driven by the weekly MACD and KST indicators, both of which are bearish. The daily moving averages also reflect a bearish sentiment. However, the monthly Bollinger Bands indicate a bullish outlook, suggesting some potential for upward movement. The Dow Theory shows a mildly bullish signal on the weekly timeframe, but overall, the mixed signals across different indicators suggest a cautious approach...."
      },
      {
        "title": "Fermenta Biotech Faces Mixed Technical Trends Amid Market Evaluation Revision",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/fermenta-biotechs-technical-trend-shifts-from-bearish-to-mildly-bearish-amid-price-increase-3700519",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/FermentaBiotech_technicaldot_3700519.png",
        "date": "2025-11-14 08:01:41",
        "description": "Fermenta Biotech, a microcap in the Pharmaceuticals and Biotechnology sector, has recently revised its evaluation amid fluctuating market conditions. The stock has seen a year-to-date decline, contrasting with the Sensex's performance, while its three-year returns have outpaced the index, indicating a complex market position."
      },
      {
        "title": "Why is Fermenta Biotec. falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-fermenta-biotec-fallingrising-3698610",
        "imagepath": "",
        "date": "2025-11-13 22:26:11",
        "description": "As of 13-Nov, Fermenta Biotech Ltd's stock price is currently at 291.15, reflecting an increase of 5.8, or 2.03%. The stock has shown a strong performance today, having outperformed its sector by 1.82% and achieving a consecutive gain over the last two days, resulting in an overall return of 8.84% during this period. It opened with a notable gain of 3.26% and reached an intraday high of Rs 298.9, indicating positive momentum. Additionally, the stock's delivery volume has significantly increased, rising by 187.2% compared to the 5-day average, which suggests heightened investor interest. However, the stock's year-to-date performance remains down by 20.00%, and it has underperformed against the benchmark over the longer term, particularly in the 1-month and 1-year periods.\n\nBroader Market Context: In the short term, Fermenta Biotech's stock has outperformed the Sensex, which has increased by 1.40% over the pa..."
      },
      {
        "title": "How has been the historical performance of Fermenta Biotec.?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/how-has-been-the-historical-performance-of-fermenta-biotec-3694582",
        "imagepath": "",
        "date": "2025-11-12 23:47:13",
        "description": "Answer:\nThe historical performance of Fermenta Biotec shows a fluctuating trend over the years, with significant changes in net sales, profits, and overall financial health.\n\nBreakdown:\nFermenta Biotec's net sales increased from 335.66 Cr in Mar'24 to 469.48 Cr in Mar'25, marking a notable recovery from previous years. The total operating income followed a similar trend, rising to 469.48 Cr in Mar'25 from 335.66 Cr in Mar'24. However, total expenditure also increased, reaching 359.68 Cr in Mar'25, up from 308.15 Cr in Mar'24. This led to an operating profit (PBDIT) of 121.62 Cr in Mar'25, a substantial increase from 39.32 Cr in the previous year. Profit before tax turned positive at 83.21 Cr in Mar'25, compared to a loss of 9.87 Cr in Mar'24, resulting in a profit after tax of 76.40 Cr, a significant turnaround from the loss of 24.01 Cr in Mar'24. The company's total assets increased to 585.83 Cr in Mar'25 ..."
      },
      {
        "title": "Are Fermenta Biotec. latest results good or bad?",
        "link": "https://www.marketsmojo.com/news/result-analysis/are-fermenta-biotec-latest-results-good-or-bad-3693173",
        "imagepath": "",
        "date": "2025-11-12 19:28:26",
        "description": "Fermenta Biotech's latest financial results for Q2 FY26 present a complex picture of operational performance. The company reported net sales of ₹130.22 crores, reflecting a year-on-year growth of 37.03%, which is a significant recovery from the previous year. However, this figure also indicates a sequential decline of 4.43% from the prior quarter, marking the third consecutive quarter of decreasing revenues since reaching a peak of ₹156.47 crores in Q4 FY25. \n\nIn terms of profitability, Fermenta achieved a net profit of ₹18.88 crores, which represents a year-on-year increase of 65.91%. Yet, this also shows a decline of 13.51% compared to the previous quarter. The operating margin for the quarter stood at 20.46%, showing a slight year-on-year improvement of 0.70% but a decrease from the previous quarter's 20.72%. Similarly, the profit after tax margin was reported at 13.85%, up from 11.70% in the same quarte..."
      },
      {
        "title": "Fermenta Biotech Q2 FY26: Profit Growth Slows Amid Margin Pressure",
        "link": "https://www.marketsmojo.com/news/result-analysis/fermenta-biotech-q2-fy26-profit-growth-slows-amid-margin-pressure-3692145",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/FermentaBiotech_quaterlyResult_3692145.png",
        "date": "2025-11-12 09:34:34",
        "description": "Fermenta Biotech Limited, a Mumbai-based pharmaceuticals and biotechnology company, reported a consolidated net profit of ₹18.88 crores for Q2 FY26, representing a 65.91% year-on-year increase but a concerning 13.51% sequential decline from Q1 FY26's ₹21.83 crores. The ₹848 crore market capitalisation company witnessed its stock surge 7.66% to ₹288.00 following the results announcement, though the company continues to grapple with margin compression and operational challenges that have kept it in bearish technical territory."
      }
    ],
    "total": 511,
    "sid": "261671",
    "stock_news_url": "https://www.marketsmojo.com/news/fermenta-biotech-261671"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
      "datetime": "02-Dec-2025",
      "details": "Intimation of investor meeting.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
      "datetime": "12-Nov-2025",
      "details": "Investor presentation H1/FY26",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "12-Nov-2025",
      "details": "Publication of unaudited financial results for the quarter and half year ended September 30 2025.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Fermenta Biotech Ltd has declared <strong>50%</strong> dividend, ex-date: 06 Aug 25",
          "dt": "2025-08-06",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Fermenta Biotech Ltd has announced <strong>5:5</strong> stock split, ex-date: 08 Aug 18",
          "dt": "2018-08-08",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Fermenta Biotech Ltd has announced <strong>2:1</strong> bonus issue, ex-date: 13 Feb 20",
          "dt": "2020-02-13",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Fermenta Biotec. Sees Revision in Market Evaluation Amid Mixed Financial Signals

2025-11-30 10:24:23

Fermenta Biotec., a microcap player in the Pharmaceuticals & Biotechnology sector, has experienced a revision in its market evaluation reflecting shifts in its fundamental and technical outlook. This adjustment follows a detailed reassessment of the company’s quality, valuation, financial trends, and technical indicators, providing investors with a nuanced perspective on its current standing.

Fermenta Biotech Faces Bearish Technical Trends Amid Mixed Performance Indicators

2025-11-18 08:03:45

Fermenta Biotech, a microcap in the Pharmaceuticals and Biotechnology sector, has seen its stock price decline recently, reflecting mixed performance against the Sensex. While it has outperformed the index monthly and over three years, year-to-date results show significant challenges, necessitating close monitoring of market conditions.

Why is Fermenta Biotec. falling/rising?

2025-11-17 22:24:03

As of 17-Nov, Fermenta Biotech Ltd's stock is currently priced at 276.80, reflecting a decline of 15.05 points or 5.16%. The stock has been underperforming, having fallen consecutively for the last two days with a total drop of 5.19%. It opened the day with a loss of 2.18% and reached an intraday low of Rs 274.5, which is a decrease of 5.94%. The stock's performance over the past week shows a slight decline of 0.18%, while it has gained 5.07% over the past month. However, year-to-date, it is down 23.95%, contrasting sharply with the Sensex, which has increased by 8.72%. There is a notable decrease in investor participation, with delivery volume dropping by 62.9% compared to the five-day average, indicating a lack of confidence among investors. Broader Market Context: In the context of the broader market, Fermenta Biotech's recent performance has been unfavorable compared to the Sensex, which has gained 1.6...

Is Fermenta Biotec. technically bullish or bearish?

2025-11-14 08:10:47

As of 13 November 2025, the technical trend for Fermenta Biotec has changed from bearish to mildly bearish. The current stance is mildly bearish, primarily driven by the weekly MACD and KST indicators, both of which are bearish. The daily moving averages also reflect a bearish sentiment. However, the monthly Bollinger Bands indicate a bullish outlook, suggesting some potential for upward movement. The Dow Theory shows a mildly bullish signal on the weekly timeframe, but overall, the mixed signals across different indicators suggest a cautious approach....

Fermenta Biotech Faces Mixed Technical Trends Amid Market Evaluation Revision

2025-11-14 08:01:41

Fermenta Biotech, a microcap in the Pharmaceuticals and Biotechnology sector, has recently revised its evaluation amid fluctuating market conditions. The stock has seen a year-to-date decline, contrasting with the Sensex's performance, while its three-year returns have outpaced the index, indicating a complex market position.

Why is Fermenta Biotec. falling/rising?

2025-11-13 22:26:11

As of 13-Nov, Fermenta Biotech Ltd's stock price is currently at 291.15, reflecting an increase of 5.8, or 2.03%. The stock has shown a strong performance today, having outperformed its sector by 1.82% and achieving a consecutive gain over the last two days, resulting in an overall return of 8.84% during this period. It opened with a notable gain of 3.26% and reached an intraday high of Rs 298.9, indicating positive momentum. Additionally, the stock's delivery volume has significantly increased, rising by 187.2% compared to the 5-day average, which suggests heightened investor interest. However, the stock's year-to-date performance remains down by 20.00%, and it has underperformed against the benchmark over the longer term, particularly in the 1-month and 1-year periods. Broader Market Context: In the short term, Fermenta Biotech's stock has outperformed the Sensex, which has increased by 1.40% over the pa...

How has been the historical performance of Fermenta Biotec.?

2025-11-12 23:47:13

Answer: The historical performance of Fermenta Biotec shows a fluctuating trend over the years, with significant changes in net sales, profits, and overall financial health. Breakdown: Fermenta Biotec's net sales increased from 335.66 Cr in Mar'24 to 469.48 Cr in Mar'25, marking a notable recovery from previous years. The total operating income followed a similar trend, rising to 469.48 Cr in Mar'25 from 335.66 Cr in Mar'24. However, total expenditure also increased, reaching 359.68 Cr in Mar'25, up from 308.15 Cr in Mar'24. This led to an operating profit (PBDIT) of 121.62 Cr in Mar'25, a substantial increase from 39.32 Cr in the previous year. Profit before tax turned positive at 83.21 Cr in Mar'25, compared to a loss of 9.87 Cr in Mar'24, resulting in a profit after tax of 76.40 Cr, a significant turnaround from the loss of 24.01 Cr in Mar'24. The company's total assets increased to 585.83 Cr in Mar'25 ...

Are Fermenta Biotec. latest results good or bad?

2025-11-12 19:28:26

Fermenta Biotech's latest financial results for Q2 FY26 present a complex picture of operational performance. The company reported net sales of ₹130.22 crores, reflecting a year-on-year growth of 37.03%, which is a significant recovery from the previous year. However, this figure also indicates a sequential decline of 4.43% from the prior quarter, marking the third consecutive quarter of decreasing revenues since reaching a peak of ₹156.47 crores in Q4 FY25. In terms of profitability, Fermenta achieved a net profit of ₹18.88 crores, which represents a year-on-year increase of 65.91%. Yet, this also shows a decline of 13.51% compared to the previous quarter. The operating margin for the quarter stood at 20.46%, showing a slight year-on-year improvement of 0.70% but a decrease from the previous quarter's 20.72%. Similarly, the profit after tax margin was reported at 13.85%, up from 11.70% in the same quarte...

Fermenta Biotech Q2 FY26: Profit Growth Slows Amid Margin Pressure

2025-11-12 09:34:34

Fermenta Biotech Limited, a Mumbai-based pharmaceuticals and biotechnology company, reported a consolidated net profit of ₹18.88 crores for Q2 FY26, representing a 65.91% year-on-year increase but a concerning 13.51% sequential decline from Q1 FY26's ₹21.83 crores. The ₹848 crore market capitalisation company witnessed its stock surge 7.66% to ₹288.00 following the results announcement, though the company continues to grapple with margin compression and operational challenges that have kept it in bearish technical territory.

View All News